Literature DB >> 19231753

Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities.

William M McClellan1, Scott G Satko, Elisa Gladstone, Jenna O Krisher, Andrew S Narva, Barry I Freedman.   

Abstract

Activities intended to improve the detection, treatment, and control of chronic kidney disease (CKD) should be incorporated into existing health care systems and targeted to high-risk populations to avoid redundancy and waste of resources. One high-risk population consists of first- or second-degree family members of patients with end-stage renal disease (ESRD), who are 2 to 3 times as likely to have incident ESRD, have high rates of impaired kidney function and undetected and uncontrolled high blood pressure, and are more likely to be obese. These individuals usually are unaware of their underlying CKD and may discount their own risk of ESRD. The ESRD Network 6 Family History Project shows that the ESRD Networks, which constitute a national CKD surveillance system for patients with stage 5 CKD, may be an existing resource that can be used to identify relatives of incident patients with ESRD and provide these families with information about CKD. Nationally available resources have been developed by the National Kidney Disease Education Program for use with these at-risk families. Individuals interested in population-based CKD control activities should be aware of and use these resources.

Entities:  

Mesh:

Year:  2009        PMID: 19231753     DOI: 10.1053/j.ajkd.2008.07.059

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  15 in total

1.  Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD.

Authors:  William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Rachel E Patzer; Brian D Bradbury; Leslie A McClure; Britt B Newsome; George Howard
Journal:  Am J Kidney Dis       Date:  2011-11-10       Impact factor: 8.860

2.  Transplantation: Increased ESRD and mortality risk for kidney donors?

Authors:  Arthur J Matas
Journal:  Nat Rev Nephrol       Date:  2014-01-21       Impact factor: 28.314

Review 3.  Genomic medicine for kidney disease.

Authors:  Emily E Groopman; Hila Milo Rasouly; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2018-01-08       Impact factor: 28.314

4.  Monogenic causes of chronic kidney disease in adults.

Authors:  Dervla M Connaughton; Claire Kennedy; Shirlee Shril; Nina Mann; Susan L Murray; Patrick A Williams; Eoin Conlon; Makiko Nakayama; Amelie T van der Ven; Hadas Ityel; Franziska Kause; Caroline M Kolvenbach; Rufeng Dai; Asaf Vivante; Daniela A Braun; Ronen Schneider; Thomas M Kitzler; Brona Moloney; Conor P Moran; John S Smyth; Alan Kennedy; Katherine Benson; Caragh Stapleton; Mark Denton; Colm Magee; Conall M O'Seaghdha; William D Plant; Matthew D Griffin; Atif Awan; Clodagh Sweeney; Shrikant M Mane; Richard P Lifton; Brenda Griffin; Sean Leavey; Liam Casserly; Declan G de Freitas; John Holian; Anthony Dorman; Brendan Doyle; Peter J Lavin; Mark A Little; Peter J Conlon; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2019-02-14       Impact factor: 10.612

5.  Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment.

Authors:  Yasar Caliskan; Brian Lee; Adrian Whelan; Fadee Abualrub; Krista L Lentine; Arksarapuk Jittirat
Journal:  Curr Transplant Rep       Date:  2022-03-16

Review 6.  A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology.

Authors:  Abraham W Aron; Neera K Dahl; Whitney Besse
Journal:  Kidney360       Date:  2022-07-08

Review 7.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

8.  Diagnostic Utility of Exome Sequencing for Kidney Disease.

Authors:  Emily E Groopman; Maddalena Marasa; Sophia Cameron-Christie; Slavé Petrovski; Vimla S Aggarwal; Hila Milo-Rasouly; Yifu Li; Junying Zhang; Jordan Nestor; Priya Krithivasan; Wan Yee Lam; Adele Mitrotti; Stacy Piva; Byum H Kil; Debanjana Chatterjee; Rachel Reingold; Drew Bradbury; Michael DiVecchia; Holly Snyder; Xueru Mu; Karla Mehl; Olivia Balderes; David A Fasel; Chunhua Weng; Jai Radhakrishnan; Pietro Canetta; Gerald B Appel; Andrew S Bomback; Wooin Ahn; Natalie S Uy; Shumyle Alam; David J Cohen; Russell J Crew; Geoffrey K Dube; Maya K Rao; Sitharthan Kamalakaran; Brett Copeland; Zhong Ren; Joshua Bridgers; Colin D Malone; Caroline M Mebane; Neha Dagaonkar; Bengt C Fellström; Carolina Haefliger; Sumit Mohan; Simone Sanna-Cherchi; Krzysztof Kiryluk; Jan Fleckner; Ruth March; Adam Platt; David B Goldstein; Ali G Gharavi
Journal:  N Engl J Med       Date:  2018-12-26       Impact factor: 176.079

9.  Association of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score.

Authors:  Jiun-Chi Huang; Szu-Chia Chen; Ming-Yen Lin; Jer-Ming Chang; Shang-Jyh Hwang; Jer-Chia Tsai; Hung-Chun Chen
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

10.  Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study.

Authors:  Amber E Johnson; L Ebony Boulware; Cheryl A M Anderson; Tatpong Chit-ua-aree; Kimberly Kahan; LaPricia Lewis Boyér; Yang Liu; Deidra C Crews
Journal:  BMC Nephrol       Date:  2014-12-06       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.